26 May 2026

strategyland.uk

Smiths Group PLC (SMIN)

Rank #25 of 100 - Consumer Non-Cyclicals - UK Equities

Home/Stocks/Consumer Non-Cyclicals

Smiths Group PLC

SMIN.L·Consumer Non-Cyclicals·Market Cap £7.5b

Rank #25 of 100

Data from Excel Model · 100 Stocks Analysed

£24.72

+5.48% YTD

Target: £27.29(+10.4%)

52W: £20.88 - £27.46

Score Analysis

Smiths Group PLC is ranked #25 out of 100 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

55/100

Average Score

Liquidity

Excellent16/100

Valuation

Fair54/100

Profitability

Good30/100

Solvency

Weak61/100

Asset Efficiency

Weak65/100

Mkt Trading

Weak67/100

Technical

Weak92/100

1. Valuation

Score: 54/100

Is SMIN undervalued compared to its peers and fair value metrics?

0/5

valuation criteria met

✗

FY26e P/E Ratio

23.6xRank 87/100

✗

FY27e P/E Ratio

19.7xRank 87/100

✗

Price-to-Book

3.81xRank 59/100

✗

Price-to-Tangible Book

10.31xRank 57/100

✗

EV/EBITDA

13.5xRank 71/100

Key Valuation Metrics

Current P/E

43.4x

Price-to-Earnings

FY26e P/E

23.6x

Forward estimate

FY27e P/E

19.7x

Forward estimate

P/B Ratio

3.81x

Price-to-Book

P/TBV

10.31x

Price-to-Tangible Book

EV/EBITDA

13.5x

Enterprise Value

FY26e EV/EBITDA

16.8x

Forward estimate

FY27e EV/EBITDA

16.8x

Forward estimate

Analyst Consensus Target

Current Price

£24.72

Consensus Target

£27.29

Potential

+10.4%

Target

Bloomberg Median Target: £27.50

2. Profitability

Score: 30/100

How profitable is SMIN relative to its peers?

1/6

profitability criteria met

✓

TTM Profit Margin

8.6%Rank 36/100

–

Current ROE

12.8%

–

Current ROA

N/A

✗

FY26e EPS

1.23Rank 47/100

–

TTM EPS

1.20

–

Net Income Growth

N/A

Profit Margin

8.6%

ROE

12.8%

FY27e ROE

18.3%

ROA

N/A

Earnings Per Share

3. Financial Health

Score: 61/100

How strong is SMIN's balance sheet and financial position?

0/4

solvency criteria met

–

Debt-to-Equity

32.2%

–

Interest Coverage

N/A

✗

Debt/EBITDA

Rank 82Rank 82/100

–

Altman Z-Score

4.25

Key Health Metrics

Quick Ratio

1.56

Healthy

Cash Ratio

2.18

Debt/Equity

32%

FCF Margin

0.9%

Altman Z-Score

4.25

Safe Zone

01.812.995+

4. Asset Efficiency

Score: 65/100

How efficiently does SMIN deploy its assets and intellectual capital?

1/2

asset efficiency criteria met

–

Intangible/Asset

Intangible assets as a proportion of total assets — lower indicates more tangible, capital-efficient operations

N/A

✓

R&D/Sales

Research & development spend relative to revenue — balanced R&D investment signals sustainable growth

Rank 9/100

Overall Asset Efficiency Rank

Rank within sector peers#65/100

Best (1)Worst (100)

What This Measures

Intangible/Asset — a lower ratio suggests the company's value is backed by tangible assets rather than goodwill or intangibles, reducing balance sheet risk.

R&D/Sales — captures the proportion of revenue reinvested into research and development, indicating innovation intensity and future growth investment.